TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial.

Sebastian Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.